| Inflammation and liver cancer: molecular mechanisms and therapeutic targets YM Yang, SY Kim, E Seki Seminars in liver disease 39 (01), 026-042, 2019 | 314 | 2019 |
| TNFα in liver fibrosis YM Yang, E Seki Current pathobiology reports 3, 253-261, 2015 | 188 | 2015 |
| Decrease of microRNA‐122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid YM Yang, SY Seo, TH Kim, SG Kim Hepatology 56 (6), 2209-2220, 2012 | 144 | 2012 |
| Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis YM Yang, M Noureddin, C Liu, K Ohashi, SY Kim, D Ramnath, EE Powell, ... Science translational medicine 11 (496), eaat9284, 2019 | 107 | 2019 |
| microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression MJ Heo, YM Kim, JH Koo, YM Yang, J An, SK Lee, SJ Lee, KM Kim, ... Oncotarget 5 (9), 2792, 2014 | 99 | 2014 |
| Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis YW Kim, YM Kim, YM Yang, TH Kim, SJ Hwang, JR Lee, SC Kim, SG Kim Free Radical Biology and Medicine 48 (4), 567-578, 2010 | 94 | 2010 |
| Crosstalk between oxidative stress and inflammatory liver injury in the pathogenesis of alcoholic liver disease YM Yang, YE Cho, S Hwang International journal of molecular sciences 23 (2), 774, 2022 | 93 | 2022 |
| NOD‐like receptor C4 inflammasome regulates the growth of colon cancer liver metastasis in NAFLD K Ohashi, Z Wang, YM Yang, S Billet, W Tu, M Pimienta, SL Cassel, ... Hepatology 70 (5), 1582-1599, 2019 | 61 | 2019 |
| TRIF differentially regulates hepatic steatosis and inflammation/fibrosis in mice L Yang, K Miura, B Zhang, H Matsushita, YM Yang, S Liang, J Song, ... Cellular and molecular gastroenterology and hepatology 3 (3), 469-483, 2017 | 60 | 2017 |
| Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate–activated protein kinase–p70 ribosomal S6 kinase‐1 … EJ Bae, YM Yang, JW Kim, SG Kim Hepatology 46 (3), 730-739, 2007 | 60 | 2007 |
| Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gαi … HM Wu, YM Yang, SG Kim Molecular Pharmacology 80 (5), 859-869, 2011 | 59 | 2011 |
| The contribution of toll‐like receptor signaling to the development of liver fibrosis and cancer in hepatocyte‐specific TAK1‐deleted mice IJ Song, YM Yang, S Inokuchi‐Shimizu, YS Roh, L Yang, E Seki International journal of cancer 142 (1), 81-91, 2018 | 58 | 2018 |
| AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability YM Yang, CY Han, YJ Kim, SG Kim World journal of gastroenterology: WJG 16 (30), 3731, 2010 | 55 | 2010 |
| Inhibition of liver X receptor-α-dependent hepatic steatosis by isoliquiritigenin, a licorice antioxidant flavonoid, as mediated by JNK1 inhibition YM Kim, TH Kim, YW Kim, YM Yang, SJ Hwang, JR Lee, SC Kim, SG Kim Free Radical Biology and Medicine 49 (11), 1722-1734, 2010 | 52 | 2010 |
| Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial–mesenchymal transition of hepatocellular carcinoma YM Yang, WH Lee, CG Lee, J An, ES Kim, SH Kim, SK Lee, CH Lee, ... Oncogene 34 (22), 2910-2921, 2015 | 51 | 2015 |
| Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration TH Kim, YM Yang, CY Han, JH Koo, H Oh, SS Kim, BH You, YH Choi, ... The Journal of clinical investigation 128 (12), 5587-5602, 2018 | 46 | 2018 |
| Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction YM Yang, CG Lee, JH Koo, TH Kim, JM Lee, J An, KM Kim, SG Kim Oncotarget 6 (22), 19055, 2015 | 46 | 2015 |
| Transactivation of genes encoding for phase II enzymes and phase III transporters by phytochemical antioxidants YM Yang, K Noh, CY Han, SG Kim Molecules 15 (9), 6332-6348, 2010 | 43 | 2010 |
| Gα12 gep oncogene inhibits FOXO1 in hepatocellular carcinoma as a consequence of miR-135b and miR-194 dysregulation HS Jung, YR Seo, YM Yang, JH Koo, J An, SJ Lee, KM Kim, SG Kim Cellular signalling 26 (7), 1456-1465, 2014 | 42 | 2014 |
| Gα12/13 signaling in metabolic diseases YM Yang, DS Kuen, Y Chung, H Kurose, SG Kim Experimental & Molecular Medicine 52 (6), 896-910, 2020 | 33 | 2020 |
